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Abstract
The optometric management of myopia has traditionally involved prescribing concave spectacle lenses or contact lenses to mitigate the 
blurred distance vision caused by ‘short sight’. However, these traditional optical corrections do not actively address or retard the progressive 
element of myopia which has been identified as a long-term ocular health concern. Given the increasing prevalence of myopia across the 
world,1 including in the UK,2 researchers have been concentrating on addressing this public health concern by exploring methods to prevent 
myopia onset and to slow myopia progression. Myopia management strategies aim to reduce myopia onset and progression, minimising the 
long-term risk of developing myopia-associated ocular pathology, instead of merely correcting myopic defocus. The present article discusses 
risk factors for myopia development, methods for predicting myopia progression and reviews the available optometric myopia management 
options for practitioners in the UK following recent publications of global and national guidance.3 Present-day research is discussed along 
with possible future interventions for myopia management in the UK.
Introduction
Myopia has become a global concern. 
Recent projections estimate that 50% of 
the global population will be myopic by 
2050 (Figure 1).1 This equates to roughly 
five billion people worldwide. Myopia 
prevalence varies geographically and in 
some parts of the world has been likened 
to an epidemic affecting large proportions 
of the population. For example, in Hong 
Kong, 18.3% of 6-year-old children are 
myopic and 0.7% are highly myopic 
(<–6.00 D); by the age of 12 these figures 
reach 61.5% and 3.8%, respectively.4 
In Korea, 96.5% of 19-year-olds are 
myopic5 and in Shanghai, China, 95.5% of 
university students are myopic.6 
In the UK, the amount of people affected 
by myopia is relatively small compared 
to Eastern Asia; however, research has 
shown that UK myopia prevalence is 
rising. The Northern Ireland Childhood 
Errors of Refraction (NICER) study is 
the largest study in the UK to examine 
how children’s cycloplegic refractive 
error changes through childhood and 
adolescence. Relating contemporary 
refractive error data with comparable 
data published in the 1960s,7 the NICER 
study demonstrated that the prevalence 
of myopia in UK teenagers has more 
than doubled in the previous 50 years 
– from 7.2% in the 1950s to 16.4% in 
the first decade of the 21st century.2,7,8 
Myopia was also found to be occurring 
at a younger age than previously 
recorded.2 This is of concern due to the 
progressive nature of myopia: the younger 
myopia begins, the greater potential for 
ocular growth and therefore associated 
pathology. The rising prevalence of 
myopia has been recognised as a global 
concern by the World Health Organization 
(WHO)9 and is featured as a research 
priority by many funding bodies. 
It has long been recognised that 
individuals with high myopia (>–6.00D) 
are at risk of myopia-associated 
pathology including potentially blinding 
conditions such as macular degeneration, 
glaucoma, cataract and retinal 
detachment.10 However, Flitcroft (2012) 
demonstrated that even individuals with 
relatively low levels of myopia (–1.00 to 
–6.00 DS) have significantly increased 
risks of developing ocular disease (Table 
1).11 In a unique analysis, Flitcroft 
compared the risk of ocular disease 
associated with myopia with the risk of 
cardiovascular disease associated with 
hypertension and smoking. Low levels of 
myopia (–1.00 to –6.00 DS), traditionally 
referred to as ‘physiological myopia’, 
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Figure 1. Graph showing the number of people estimated to have myopia and high myopia for each decade from 2000 to 
2050. Error bars represent the 95% confidence intervals. (Reproduced from Holden et al. (2016),1 with permission.) 
Table 1. The odds of glaucoma, posterior subcapsular (PSC) cataract, retinal detachment and myopic maculopathy occurring 
in individuals with increasing dioptres (D) of myopia, compared to those without myopia, as shown by odds ratio values 
summarised from Flitcroft (2012)11
Glaucoma PSC cataract Retinal detachment Myopic maculopathy
2.3 
–1.00 to –3.00 D
2.1 
–1.00 to –3.50 D
3.1
–0.75 to –2.75 D
2.2
–1.00 to –2.99 D
3.3 
< –3.00 D
3.1
–3.50 to –6.00 D
9.0
–3.00 to –5.75 D
9.7
–3.00 to –4.99 D
5.5
< –6.00 D
21.5
–6.00 to –8.75 D
40.6
–5.00 to –6.99 D
44.2
–9.00 to –14.75 D
126.8
–7.00 to –8.99 D
88.2
≤ –15.00 D
348.6 
≤ –9.00 D
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were found to be a high-risk factor for 
ocular disease, comparable to the risk 
hypertension has for cardiovascular 
disease. The risk of glaucoma or cataract 
in myopic individuals was similar to the 
risk of stroke from smoking >20 cigarettes 
per day, and the risk of retinal detachment 
or maculopathy was in excess of any 
documented risk factor for cardiovascular 
disease. This fascinating analogy is 
relevant to optometrists relaying the 
importance of myopia management to 
patients, parents and the wider public. 
Recent guidelines and 
consensus on myopia 
management
In 2018, the College of Optometrists 
undertook an inaugural collaborative, 
interprofessional exercise to produce 
myopia management guidance for UK 
optometrists. The resultant College 
guidance (published in 2019) articulates 
that, while there was, at time of 
publication, insufficient evidence to 
support the widespread roll-out of 
myopia control strategies in the UK, 
practitioners who already offer myopia 
management can continue to do so safely 
and ethically, so long as sector guidance 
is adhered to. This advice will likely be 
re-evaluated as evidence for myopia 
management strategies in UK populations 
accumulates. Full guidance can be found 
on the College website (www.college-
optometrists.org).
Concurrently, the International Myopia 
Institute (IMI) published a comprehensive 
series of open-access ‘white papers’ 
generating consensus covering 
myopia definitions and classifications, 
experimental models, interventions, 
clinical trials and instrumentation, 
industry guidelines and ethics, clinical 
management and genetics (www.
myopiainstitute.org). The clinical myopia 
management guidelines paper provides 
advice and information for clinical 
practice.12 It details evidence-based 
management of the pre-myope, stable 
myope and progressing myope, including 
risk factor identification, examination, 
selection of treatment strategies and 
guidelines for ongoing management. 
Assessing risk factors for 
myopia development and 
progression
In clinical practice it is important to be 
able to identify individuals at risk of 
developing myopia.13 Known risk factors 
include patient age, refractive error, 
recent eye growth, parental myopia, 
ethnicity, visual environment, education 
and binocular function. These quantifiable 
risk factors prompted the IMI to format a 
definition for ‘pre-myopia’. This definition 
aims to help practitioners identify non-
myopic children who have the greatest 
risk of myopia development:
  Pre-myopia – a refractive state of an eye 
of ≤+0.75 D and >–0.50 D in children 
where a combination of baseline 
refraction, age, and other quantifiable 
risk factors provide a sufficient 
likelihood of the future development 
of myopia to merit preventative 
interventions14
The IMI note that this definition relates to 
refractive state when accommodation is 
relaxed, and do not clarify what age they 
consider ‘children’ in their definition (see 
below for more age-specific values related 
to refractive error). Optometrists in 
primary care settings are clearly in a good 
position to identify individuals at risk of 
myopia. Individuals with pre-myopia may 
benefit from behavioural advice, discussed 
later, and should be monitored closely 
(annually or biannually) for myopia onset. 
Age, refractive error, ocular biometry 
and rate of recent eye growth
In the UK, myopia is most likely to 
occur between 6 and 13 years of age.2 
Young infants with relatively high levels 
of myopia should be investigated for 
possible syndromic links to their refractive 
error. Low levels of hyperopia indicate a 
high risk for future myopia development 
and this ‘at-risk’ level of hyperopia  
reduces as children grow older. For 
example, a cycloplegic autorefraction of 
+0.75 D or less in a 6-year-old, ≤+0.50 in 
a 7–8-year-old, ≤+0.25 in a 9–10-year-
old and emmetropia in an 11-year-old 
have all been associated with a high 
risk for future myopia development.13 
Where axial length data are available, 
rate of recent eye growth can also be 
informative in identifying children likely 
to develop myopia. Axial length naturally 
increases throughout childhood. However, 
this normal expansion is typically 
counteracted by compensatory changes 
in the refractive components of the eye 
to maintain emmetropia, i.e. the lens 
thins and the cornea flattens. Myopia 
results when axial growth is no longer 
compensated by changes in refractive 
components. Longitudinal data collected 
between 1995 and 2003 demonstrated 
that axial length of future myopes was 
significantly longer 3 years prior to the 
onset of myopia compared to children 
who maintained emmetropia. These 
valuable data also illustrated that the 
fastest rate of eye growth occurs in the 
year prior to myopia development.15 To 
determine ‘normal’ eye growth patterns 
in childhood, a European study evaluated 
longitudinal axial length data between 
the ages of 6 and 9 years old. Researchers 
reported an overall average increase in 
axial length of 0.21 mm/year between 
these ages, with myopic children showing 
faster growth rates than emmetropes 
or hyperopes. The average axial length 
at 6 years of age was 22.36 mm and, 
where axial length exceeded 24 mm at 6 
years of age, 73% of boys (and a higher 
percentage of girls) were myopic by 9 
years of age.16 A similar relationship was 
found in data from UK children.17 
Parental myopia and ethnicity
UK children who have one myopic parent 
are almost three times more likely to be 
myopic by age 13 than a child with no 
myopic parents.2 This risk increases to 
over seven times more likely when both 
parents are myopic.18 Rudnicka et al. 
(2010) examined a multiethnic sample of 
British children aged 10–11 years old and 
found myopia prevalence to be 25.2%, 
10.0% and 3.4% in South Asian, black 
African Caribbean and white European 
children, respectively. Adjusted odds ratios 
showed that South Asian children were 
8.9 times more likely, and black African 
Caribbean children were 3.2 times more 
likely, to be myopic compared to white 
European peers.19 An appreciation of these 
non-modifiable risk factors for myopia 
development, in terms of ethnicity and 
family history of myopia, should be 
considered by optometrists alongside 
modifiable risk factors, discussed below.
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Visual environment: time spent 
outdoors and in near-vision activities
It is broadly accepted that genetics 
cannot exclusively explain the rapid global 
rise in myopia prevalence. Environmental 
factors must play a role, and there is 
ongoing debate whether gene inheritance 
in isolation results in myopia, or whether 
gene inheritance increases an individual’s 
susceptibility to myopia-promoting 
environments.20 Such myopia-promoting 
environments are often shaped by myopic 
parents. For example, research has shown 
that Australian children of myopic parents 
spend less time outdoors and more time 
reading than children of emmetropic 
parents.21 This indicates that myopic 
parents may promote the myopiagenic 
environments that their children 
experience, as spending both less time 
outdoors and more time in near-vision 
tasks have been associated with increased 
risk of myopia.22 A systematic review 
and meta-analysis evaluated children’s 
near-work habits and refractive error in 
10,384 participants; results suggested 
that more time spent on near-work 
activities was associated with a rather 
modest, but statistically significant, 1.14× 
higher risk of myopia.23 Spending more 
time outdoors has also been associated 
with delaying the onset, but not yet the 
progression, of childhood myopia.22  The 
protective effects of spending more time 
outdoors are apparent even if the child 
partakes in high levels of near work. Rose 
et al. (2008) examined 1,765 6-year-olds 
and 2,367 12-year-olds in the Sydney 
Myopia Study and found that higher 
levels of total time spent outdoors, 
gauged through questionnaires, were 
associated with fewer myopic refractions 
after taking the amount of time spent 
doing near work, parental myopia and 
ethnicity into account.21 Children with 
low outdoor and high near-work activity 
were 2.6× more likely to be myopic 
compared to children with high levels 
of outdoor activity and low levels of 
near work (adjusted odds ratio of 2.6; 
95% confidence interval 1.2–6) (Figure 
2). The mechanism by which spending 
more time outdoors is protective against 
the onset of myopia has not yet been 
established. Possible explanations include 
greater exposure to high levels of light 
intensity,24,25 short-wavelength light 
(360–400 nm) and ultraviolet light.26,27 
Outdoor environments also present 
a more uniform dioptric ‘diet’ for the 
visual system when compared with 
indoor environments.11 Further, as yet 
unidentified, mechanisms could also be 
implicated. 
Education
Spending more years in education has 
also been linked to an increased risk 
of myopia. The impact of education is 
difficult to evaluate in isolation from 
other risk factors such as less time spent 
outdoors and increased near work – 
factors which are likely interlinked. A 
UK Biobank study explored 44 genetic 
variants associated with myopia and 69 
genetic variants associated with years 
of schooling in 67,798 men and women, 
aged 40–69 years, and found that 
each additional year of education was 
associated with 0.27 D more myopia.28 
Attending an academically selected school 
is also associated with a significantly 
increased risk of myopia in UK and 
Australian children.18,29 
Binocular function
Reduced accommodative facility30 and 
higher levels of esophoria, accommodative 
lag31,32 and accommodative convergence 
to accommodation (AC/A) ratios33,34 
have been reported in myopes compared 
to emmetropes. However, it is unclear 
whether these observations are 
causative or a feature of myopia.12 Lag 
in accommodation induces hyperopic 
defocus during near work, where the 
image is focused behind the retina, and 
has been postulated to encourage axial 
elongation. Similarly, other binocular 
vision anomalies may promote myopia 
progression and research suggests that 
the efficacy of myopia management 
strategies may be influenced by binocular 
status35; further work in this area may 
help practitioners to stratify management 
options in the future. In the meantime, 
binocular status should be explored 
before starting myopia management 
and reassessed following intervention to 
ensure binocular fusion is maintained.
Predicting myopia progression
Myopia progression is typically more rapid 
in younger individuals, those with higher 
baseline myopia and those who have 
experienced >0.50 D myopia progression 
in the previous year.36-38 Myopia also 
seems to progress more rapidly in winter 
than in summer months.39 However, 
progression is difficult to predict on an 
individual basis. Having the ability to 
estimate progression would be beneficial 
when counselling myopic individuals 
about their likely end-point refractive 
error and determining which patients 
would benefit most from intervention. 
The Brien Holden Vision Institute (BHVI) 
myopia calculator is a web-based tool 
which uses peer-reviewed data40 to 
Figure 2. Multivariable-adjusted odds ratios (adjusted for gender, ethnicity, parental myopia, parental employment and 
education) for myopia by reported average daily hours spent on near work versus outdoor activities in 12-year-olds. Activities 
were divided into tertiles of high, moderate and low levels of activity. The group with high levels of outdoor activity and low 
levels of near work is the reference group. (Reproduced from Rose et al. (2008), 21 with permission.) 
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estimate likely myopia progression based 
on ethnicity (Caucasian or Asian), age 
(6–16 years old) and presenting refractive 
error (–0.50 to –5.00 D) (https://
calculator.brienholdenvision.org). 
The BHVI calculator also allows users 
to compare the predicted progression 
trajectory with the anticipated refractive 
outcome when different myopia 
management strategies are applied. 
This online calculator provides easy-to-
interpret graphics to illustrate to parents 
and patients what they may expect with 
and without intervention. Outputs should 
be interpreted with caution as the data 
used by the myopia calculator are derived 
from the control arms of intervention 
trials in the USA and may not be entirely 
applicable to clinical populations living 
in the UK.41 In addition, predicted 
progression trajectories are extrapolated 
from the efficacy of relatively short 
intervention trials. Intervention studies 
generally show greatest myopia control 
efficacy in the first year of treatment with 
reducing efficacy in subsequent years of 
treatment.
Myopia management options 
available to UK optometrists
Years of research involving different 
species have improved our understanding 
of the role of visual experience and 
feedback mechanisms in influencing 
eye growth, including the excessive 
axial growth that is usually associated 
with myopia. The majority of animal 
species studied can be encouraged to 
develop myopia in response to visual 
form deprivation, are able to regulate 
axial length when hyperopic (negative 
lenses) or myopic (positive lenses) 
defocus is optically imposed and can also 
recover from these induced refractive 
errors when optical defocus or form 
deprivation interventions are removed.42 
It is clear from these animal studies 
that the retina is able to detect the sign 
of image defocus, allowing the growth 
and refractive status of the eye to be 
manipulated by imposing retinal defocus. 
Hyperopic defocus focuses light behind 
the retina and promotes axial growth 
(myopia) and, conversely, myopic defocus 
focuses light in front of the retina and 
encourages retardation of axial elongation 
(hyperopia). Initially discovered in animal 
models and more recently identified 
in humans, manipulation of peripheral 
retinal defocus whilst providing clear axial 
focus results in similar growth-regulating 
responses.43 This finding has encouraged 
the development of various optical 
intervention strategies for myopic eye 
growth, which will be discussed in the 
next section.
When considering myopia management, 
it is important to appreciate that current 
strategies aim either to reduce the risk of 
myopia onset or to limit the progression 
of myopia, as opposed to removing 
the risk of myopia onset or halting 
progression entirely. It is also important 
to consider that the efficacy of myopia 
management strategies varies significantly 
from one individual to another, and across 
research studies. This is especially true 
when percentage efficacy is considered 
rather than the cumulative absolute 
reduction in axial length, which has been 
shown to be more comparable across 
studies. 
The best evidence available for the 
impact of a particular treatment comes 
from randomised controlled trials where 
individuals and researchers are masked 
with regard to whether individual 
participants are on the treatment under 
test or a ‘placebo’. This approach is 
easier for some potential myopia control 
strategies than for others. ‘Headline’ 
outcomes, from studies evaluating the 
efficacy of myopia control strategies, 
generally relate to the average effect 
seen in the treated group, compared to 
the untreated group. However, individual 
responses to the treatment often vary 
widely from the average. The potential 
for treatments to have less than average 
or greater than average effects should be 
acknowledged and explained to patients 
and parents. Individual variation is not 
well understood but is a strong indication 
for regular follow-up and practitioners 
should be receptive to discontinuing 
strategies that are not impactful and 
exploring other management options. 
A further limitation in the research 
evidence base is the lack of long-term 
studies evidencing prolonged benefits or, 
conversely, the risks of different myopia 
management strategies. There are also 
limited data illustrating whether rebound 
effects are likely, i.e. whether once 
myopia control interventions are ceased, 
myopic eye growth (and refractive error) 
accelerates unacceptably. With these 
limitations acknowledged, optical and 
pharmacological myopia management 
strategies have demonstrated the capacity 
to slow myopia progression by up to 60%, 
and furthermore, simply encouraging 
children to spend more time outdoors can 
reduce the risk of myopia onset. In the 
following paragraphs we will briefly review 
myopia management options currently 
available to optometrists in the UK. 
Behavioural modifications
Increasing the amount of time spent 
outdoors is simple modification to 
behaviour which UK optometrists 
can encourage, especially for those at 
risk of myopia development. Studies 
examining school-aged children suggest 
8–15 hours of outdoors activity per 
week may mediate against the onset 
of myopia.44-46 However, a caveat to 
spending more time outdoors is the 
consideration of the known harmful 
effects of lifelong ultraviolet exposure. 
While there are legitimate concerns with 
respect to myopia-related ocular disease, 
the risk of skin melanoma, especially in 
countries with high ultraviolet index, 
should be acknowledged. The timing of 
outdoor exposure may also become an 
important consideration when providing 
advice for families (see section on 
sleep and circadian rhythms, below). 
Further research is required to refine the 
messages eye care professionals relay to 
parents and patients in the UK. 
Reading at close distances (<20 cm) 
and reading continuously for more than 
45 minutes have both been associated 
with a higher risk of myopia in Chinese 
children.47 It is currently unclear if 
this relationship exists in non-Chinese 
children, but it may be appropriate to 
discourage children at risk for myopia 
from using truncated reading distances 
and undertaking prolonged periods of near 
work without a break. No specific causal 
link has been established to date between 
screen use and myopia development or 
progression; however parents are often 
concerned about the potential impact 
of these devices on visual health and 
general well-being. Practitioners can 
refer to recent WHO guidelines when 
discussing screen use with parents of 
young children (https://apps.who.int). 
The WHO reports that sedentary screen 
time is not recommended for children 
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under the age of 2 years, that children 
aged 2–4 year olds should spend no more 
than 1 hour in sedentary screen time, and 
that less screen time is generally better. 
Excessive screen time has been negatively 
associated with diet, physical activity, 
sleep and behaviour; therefore, adherence 
to these guidelines may provide a host 
of health benefits. The 20-20-20 rule, 
commonly prescribed for digital eye strain, 
can also be recommended to children 
who partake in intense near work. Every 
20 minutes the child should be advised 
to take a 20-second break to focus on 
something at least 20 foot in the distance 
(or as far away as possible). 
Single-vision lenses
Despite the fact that single-vision 
spectacles do not actively control 
myopia progression, they remain the 
most commonly prescribed form of 
myopia correction in the UK. Studies 
evaluating the efficacy of undercorrection 
of myopia in reducing the rate of 
progression have not been promising, 
either demonstrating no effect on 
myopia progression48 or identifying an 
increasing rate of myopia progression 
when undercorrection is utilised.49,50 
Neither of these outcomes is favourable 
when considered in combination with 
the sacrifice of optimum distance visual 
acuity. Given the potential acceleration of 
myopia progression with undercorrection 
and the associated suboptimal distance 
vision, it is currently considered best 
practice to prescribe the full myopic 
prescription and advocate full-time wear 
to maximise acuity when prescribing 
single-vision distance spectacles. The 
same is true for single-vision contact 
lenses; however, given the development 
of licensed multifocal contact lenses for 
myopia control and their proven efficacy, 
discussed below, myopia control lenses 
should be the first recommendation for 
progressing myopes interested in/already 
wearing contact lenses.
Multifocal soft contact lenses
Multifocal soft contact lenses (MFSCLs) 
have been shown to reduce the rate 
of myopia progression. This is likely 
due to the induced peripheral myopic 
defocus which, as discussed previously, 
discourages axial elongation. Reported 
efficacy of MFSCLs varies across studies 
where different lens designs and wear 
modalities are utilised; however, efficacy 
usually ranges between 30% and 60% 
reduction in progression rate compared to 
control groups.51-55 Typically, lenses with a 
central correction zone for clear distance 
vision (centre-distance) and concentric 
peripheral positive addition (i.e. myopic 
defocus treatment zone) show the best 
efficacy for myopia control. Specialised 
lenses, such as CooperVision’s MiSight 
1-Day and VTi NaturalVue Multifocal 
1-Day, have been specifically licensed 
for myopia control in the UK. Fitting of 
alternative presbyopic MFSCLs, which 
are not CE-marked for myopia control, 
would be considered ‘off-label’. A recent 
3-year double-masked, randomised, 
clinical trial demonstrated 59% less 
myopic progression and 52% less axial 
elongation in 8–12-year-old children 
wearing MiSight 1-Day, compared to 
those wearing Proclear 1-Day lenses on 
the same wearing schedule (Figure 3). 
Average wearing schedule for the MiSight 
group was 13.7 hours per weekday, 12.1 
hours per weekend day and 6.5 days per 
week.56
Wearing schedule is an important factor 
when prescribing MFSCLs. Lenses will 
only have a treatment effect when 
being worn for a large portion of the 
day, therefore, parents and patients 
need to be content with the intensive 
wearing schedule. Whilst MFSCLs provide 
peripheral myopic defocus treatment in 
all directions of gaze, and provide a larger 
myopia control effect than multifocal 
spectacle lenses, contact lens wear is 
associated with complications, the most 
significant of which (microbial keratitis) 
can, in a small number of cases, result 
in visual impairment. Age is a significant 
non-linear risk factor for contact lens-
related complications. Individuals aged 
15–25 years old have the highest risk 
for corneal infiltrative and inflammatory 
events. Younger individuals aged 8–15 
years have a lower risk compared to 
older teens and adults.57 A change from 
standard contact lenses to a contact lens 
designed for myopia control is unlikely to 
pose an additional risk of complication. 
However, consideration should be given to 
wearing schedule: a longer wear time for 
best myopia control effects will impose 
a higher risk of adverse events and this 
should be fully discussed with prospective 
wearers.
Orthokeratology
Orthokeratology (OK) exploits reverse-
geometry rigid gas-permeable contact 
lenses worn overnight to remodel the 
anterior corneal surface. Remodelling 
temporarily reduces myopic refractions, 
allowing those with low to moderate 
myopia to forgo daytime spectacle wear, 
and induces peripheral myopic defocus 
which is believed to reduce myopia 
progression. Longitudinal studies and 
clinical trials have demonstrated that 
children fitted with OK lenses have 
reduced myopia progression and axial 
elongation compared to children wearing 
daytime spectacles or soft contact 
lenses.58-60 In cases of high myopia, 
‘partial’ OK may be used to reduce the 
required ‘daytime’ refractive correction 
for clear distance vision. OK therefore 
defers a dual benefit – reducing myopic 
refractions during the day and slowing 
myopia progression. For maximum 
myopia control and optimum daytime 
Figure 3. Mean unadjusted changes in (a) spherical equivalent refractive error (D) and (b) axial elongation (mm) for the test 
(MiSight) and control (Proclear 1-Day) study groups. The filled and open symbols represent the MiSight and control groups, 
respectively, for the 36-month study period. The error bars denote the 95% confidence interval of the mean changes. The 
mean unadjusted differences were 0.40 D less with MiSight at 12 months, 0.54 D less at 24 months and 0.73 D less at 36 
months. (Reproduced from Chamberlain et al. (2019),56 with permission.)
(a) (b)
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vision, lenses should be worn every night 
for a minimum of 8 hours. The safety of 
overnight OK lens wear in children over 
a 10-year wearing period is comparable 
to the safety and risk associated with 
soft contact lens wear over the same 
period.61 Myopia control effects have 
been demonstrated for up to 10 years of 
lens wear60-62; however, discontinuation of 
OK lenses after 2 years of wear has been 
shown to result in a rapid increase in axial 
elongation in children aged 8–14 years 
old.63 This reiterates that the possibility 
of post-treatment ‘rebound’ should be 
considered and discussed with parents 
before commencing myopia management 
strategies. 
Bifocal and progressive spectacles
Bifocal and progressive addition 
spectacle lenses were first prescribed to 
non-presbyopic patients as a means of 
reducing accommodative lag during near 
work, and were subsequently reported 
to have myopia control effects. However, 
it is not clear exactly how these lenses 
function to reduce myopia progression. 
Possible explanations include reducing 
accommodative demand, reducing lag of 
accommodation and/or inducing myopic 
defocus to the superior retina when 
viewing distance. In addition, the literature 
records a wide range of treatment effects. 
Cheng et al. (2011) reviewed evidence 
investigating myopia control properties 
of bifocal and progressive lenses and 
concluded that bifocal and progressive 
lenses can limit myopic progression 
in rapidly progressing individuals with 
near esophoria and/or high lags of 
accommodation.35 It was hypothesised 
that the variability in the myopia control 
effect was due to the lack of personalised 
treatment options provided within 
research studies, i.e. that most studies 
used the same near-addition power for all 
children despite differences in binocular 
status. However, a further study by Cheng 
et al. (2014) reported that the positive 
treatment effect of executive bifocals 
and executive prismatic bifocals was 
independent of near phoria status. The 
3-year trial reported 0.81 D and 1.05 D 
less myopia progression in children aged 
8–13 years who wore executive bifocals 
and executive prismatic bifocals (6∆BI) 
respectively, compared to those wearing 
single-vision lenses. This was regardless of 
the near phoria status.64 Practitioners who 
prescribe bifocal or progressive lenses to 
myopic children in clinical practice as a 
myopia control intervention should also 
consider visual comfort, cost, aesthetics, 
compliance, add accessibility, i.e. fitting 
height and progressive lens design (fitting 
height should be higher than normally 
chosen for presbyopic patients and a 
short-corridor progressive lens design 
chosen) and appropriate frame selection, 
especially for young children with 
underdeveloped bridges. 
Potential future therapies and 
antimyopia strategies
Novel spectacle lens designs
An exciting spectacle design for myopia 
control has recently been released on 
the Hong Kong and Chinese market. 
Hoya’s MyoSmart spectacle lens was 
designed with Defocus Incorporated 
Multiple Segments (DIMS) technology 
in partnership with the Hong Kong 
Polytechnic University. The DIMS lens 
consists of a central optical zone for 
correcting distance refractive error 
surrounded by a region containing a 
multitude of tiny +3.50 D ‘lenslets’ 
which provide constant myopic defocus 
extending to the lens mid-periphery 
(Figure 4). A 2-year double-masked 
randomised controlled trial of 160 
Chinese children aged 8–13 years 
found 59% less myopia progression and 
60% less axial elongation in children 
wearing DIMS lenses compared with 
those wearing the single-vision lenses. 
In addition, 21.5% of children who wore 
DIMS lenses demonstrated no myopia 
progression over 2 years, compared to 
7.4% of children wearing single-vision 
lenses.65 Novel spectacle lens designs 
are expected to become available on 
the European market, provided trials on 
European children demonstrate efficacy.
Atropine
Prolonged daily atropine eye drops (of 
varying concentrations: 1.0%, 0.5%, 
0.05%, 0.025%, 0.01%) are extensively 
prescribed ‘off-label’ for myopia 
management in Asia due to their high 
efficacy for myopia control (Figure 5). In 
contrast to original belief, atropine does 
not function through an accommodative 
mechanism. Rather, it is currently thought 
that atropine exerts its myopia control 
properties via a neurochemical cascade 
within the retina, although the exact 
mechanism remains unclear. Evidence 
demonstrates a dose-dependent efficacy 
for myopia control, where higher 
concentrations of atropine reduce myopia 
progression the most (Figure 6). However, 
increasing the concentration of atropine 
also increases side effects and shows 
greater rebound effects when treatment 
is stopped.66-68 Potential side effects of 
atropine instillation include temporary 
discomfort and blurred near vision and 
photophobia due to the accompanying 
cycloplegia and mydriasis. Atropine eye 
drops are typically instilled before bed 
to reduce daytime side effects although, 
depending on the dose, residual daytime 
effects may still prove challenging in 
terms of daily school and home activities. 
Additional spectacles may be required to 
reduce symptoms of photophobia (i.e. 
tints) and to improve near visual acuity 
(i.e. reading addition) depending on the 
prescribed dose.
Figure 4. The design of the Defocus Incorporated Multiple Segments (DIMS) spectacle lens. 
(Reproduced from Lam et al. (2019),65 with permission.)  
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Evidence for atropine’s efficacy and safety 
is almost exclusively drawn from studies 
investigating cohorts of Asian children. 
This has restricted the adoption of 
atropine treatment in western societies, 
with children of predominantly European 
ancestry, and currently atropine is not 
licensed for use as a myopia control 
agent in the UK. In addition, there is little 
consensus on how to stratify patients 
to a particular treatment dose, when 
to increase/reduce the treatment dose 
and when to cease treatment. Recent 
pilot studies have demonstrated the 
acceptability, short-term efficacy and the 
safety of low-dose atropine eye drops 
in European populations.69,70 Several 
multisite randomised clinical trials are 
currently underway in the UK and Ireland 
to evaluate myopia progression, comfort, 
visual quality and safety in European 
children. Outcomes from the treatment 
phases of the trials will be available over 
the next 3–4 years and, depending on the 
findings, low-dose atropine may be added 
to the myopia management ‘armoury’ 
of optometrists in the UK in the not too 
distant future. 
Sleep and circadian rhythms
Sleep and circadian/diurnal rhythms are 
emerging areas of interest in myopia 
research.71 The human eye is known to 
demonstrate relatively robust diurnal 
rhythms in many ocular parameters, 
including significant diurnal variation in 
central corneal thickness, corneal power, 
lens thickness, vitreous chamber depth, 
axial length, retinal thickness, choroidal 
thickness and intraocular pressure.72,73 
Perhaps of most interest to myopia 
researchers is the diurnal variation seen 
in axial length and choroidal thickness 
(Figure 7): two parameters which typically 
differ significantly between myopic and 
non-myopic eyes – longer axial length and 
thinner choroid are characteristic features 
of the myopic eye. When monitored 
over a 24-hour period, axial length and 
choroidal thickness vary in antiphase; the 
choroid is normally thickest at night and 
axial length longest during the day.
Animal research has demonstrated that 
manipulation of the timing, wavelength 
and intensity of light exposure and the 
sign (positive or negative) and timing of 
retinal defocus can disrupt these diurnal 
rhythms in choroidal thickness and 
axial length,71 and similar patterns are 
being reported in the human eye.74-76 
Australian researchers demonstrated that 
daily morning light therapy, applying 
short-wavelength light (500 nm) at a 
relatively low intensity (approximately 
500 lux), increases choroidal thickness 
and the amplitude of choroidal thickness 
variation over a 24-hour period.76 
Conversely bright light at night promotes 
choroidal thinning and reduces the 
magnitude of the diurnal variation in 
choroidal thickness.77 Recent reports also 
identify that hyperopic defocus rapidly 
promotes choroidal thinning, at least in 
a transitory fashion,78 but more potent 
to the human eye is the effect of myopic 
defocus which, particularly when applied 
in the evening,79,80 promotes choroidal 
thickening. These experiments suggest 
that the eye’s local diurnal rhythms are 
influenced by light (timing, intensity and 
spectral content) and the sign of retinal 
defocus, and each may impact singly or in 
combination on regulating ocular growth. 
Additional evidence that refractive 
errors may, at least in part, arise from 
disturbances in circadian signals to the 
eye is provided by the recent study of 
Stone et al.81 Stone et al.81 demonstrated 
that knockout of circadian genes in the 
mouse retina and fruit fly (Drosophila 
melanogaster) produces myopic 
phenotypes. In humans, at a systemic 
level, serum levels of melatonin (which 
is considered a robust biomarker for 
circadian rhythm) have been shown to 
differ between myopes and non-myopes82 
and reduced sleep quality and quantity 
have been reported in myopic individuals 
compared to non-myopic peers.83-85 
Figure 5. Summary of 
findings from the ATOM1 
and ATOM2 studies: change 
in spherical equivalent (SE). 
ATOM, Atropine for the 
Treatment of Myopia; D, 
dioptre. (Reproduced from 
Chia et al. (2016),66 with 
permission.)    
Figure 6. Change in (a) spherical equivalent (SE) and (b) axial length in treatment groups across time. D, dioptre; M, month. 
(Reproduced from Yam et al. (2018),86 with permission.)  
Figure 7. Mean (± standard error) 24-hour change in axial length (μm, black) and choroidal 
thickness (μm, red) for all subjects (n = 18); solid lines are cosinor fits to the data; grey areas 
represent the dark period. (Adapted with permission from Ostrin et al. (2019)72.)
(a) (b)
9   | Optometry in Practice The optometric management of childhood myopia: a review of the evidence
Summary 
Myopia management strategies aim to 
reduce myopia onset and progression, 
minimising the long-term risk of developing 
myopia-associated ocular pathology, 
instead of merely correcting myopic 
defocus. Evidence demonstrates good 
efficacy for interventions that aim to reduce 
myopia progression. However, there are 
some limitations to consider. The present 
article discusses risk factors for myopia 
development and methods for predicting 
myopia progression and reviews the available 
optometric myopia management options 
for practitioners in the UK following recent 
publications of global and national guidance. 
Present-day research is discussed along with 
possible future interventions for myopia 
management in the UK.
While these human data point to a relationship between the disruption of 
ocular and systemic circadian rhythms further prospective data are required 
to ascertain robustly whether these interactions influence eye growth and 
promote or inhibit the development of myopia. With more information, future 
therapies may aim to promote healthy sleep, circadian rhythm and ocular 
growth through behavioural interventions limiting evening light exposure and 
promoting daytime light exposure, and/or optical interventions which restrict 
short-wavelength exposure at night whilst allowing broad-spectrum light 
exposure throughout the day. Consideration of the timing of visual behaviours 
which promote hyperopic and myopic defocus may also be important. 
Conclusion
There is a growing number of children at risk for myopia, partly as a 
consequence of modern lifestyles and environments. Research is focused 
on ensuring that the optometrists of the future have a range of strategies, 
treatments and advice from which they can tailor a bespoke, evidence-based 
management package for each child, designed either to delay or prevent the 
onset of myopia and slow its progression. This unfolding and dynamic clinical 
area offers exciting opportunities for primary care optometrists not only to 
detect and correct refractive deficits, but to play an active role in modifying 
refractive outcomes and improving long-term visual health and quality of life.
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CPD exercise 
After reading this article, can 
you identify areas in which your 
knowledge of the optometric 
management of childhood 
myopia has been enhanced?
How do you feel you can use this 
knowledge to offer better patient 
advice?
Are there any areas you still feel 
you need to study and how might 
you do this?
Which areas outlined in the 
article would you benefit from 
reading in more depth, and why?
CET multiple choice questions
 
This article has been approved for one 
non-interactive point under the GOC’s 
Enhanced CET Scheme. The reference 
and relevant competencies are stated 
at the head of the article. To gain your 
point visit the College’s website www.
college-optometrists.org and complete 
the multiple choice questions online. The 
deadline for completion is 31 January 
2021. Please note that the answers that 
you will find online are not presented in 
the same order as in the questions below, 
to comply with GOC requirements.
1.  What is the prevalence of myopia 
in UK teenagers, as determined by 
the NICER study? 
 • 16.4%
 • 7.2%
 • 96.5%
 • 61.5%
2.  How many times more likely is a 
–4.00 D myopic individual to have 
a retinal detachment in his or her 
lifetime compared to an individual 
without myopia? 
 • 3 times
 • 15 times
 • 9 times
 • 60 times
3.  How many times more likely to be 
myopic is a child with two myopic 
parents?
 • 7
 • 2
 • 10
 • 15
4.  If prescribing single-vision 
spectacles to a progressing myope:
 •  The full myopic refraction should be 
prescribed
 • Regular reviews should be organised
 •  Behavioural advice should be 
discussed
 • All of the above
5.  Which of the following would 
be considered good behavioural 
advice for children both with, and 
at risk of, myopia?
 •  Spend more time outdoors in 
sunlight (with adequate sun 
protection)
 •  Increase near working distance (to 
more than 20 cm)
 •  Reduce time spent in continuous 
near activities (advise 20-20-20 
rule)
 • All of the above
6.  During a 3-year clinical trial, 
children wearing MiSight 1-Day 
contact lenses demonstrated 
____ % less myopia progression 
compared to peers wearing 
Proclear 1-Day lenses:
 • 59%
 • 30%
 • 100%
 • 75%
